Receptor del factor de crecimiento de fibroblastos (FGFR)
Los inhibidores de FGFR (receptores del factor de crecimiento de fibroblastos) son terapias dirigidas que bloquean la actividad de los FGFR, los cuales están involucrados en la proliferación celular, diferenciación y angiogénesis. La señalización de FGFR contribuye a la formación de nuevos vasos sanguíneos en los tumores, promoviendo su crecimiento y supervivencia. Inhibir FGFR puede, por lo tanto, reducir la angiogénesis y la progresión tumoral. En CymitQuimica, ofrecemos una gama de inhibidores de FGFR de alta calidad para apoyar su investigación en cáncer, biología del desarrollo y angiogénesis.
Productos de "Receptor del factor de crecimiento de fibroblastos (FGFR)"
Ordenar por
FGFR4-IN-14
FGFR4-IN-14 (Compound 27i) is a selective FGFR4 inhibitor with an IC50 of 2.4 nM, showing potent inhibition of cell proliferation in the V550L and N535K mutantFórmula:C27H25Cl2N5O2Pureza:98%Forma y color:SolidPeso molecular:522.43FGFR-IN-16
CAS:FGFR-IN-16 (compound 7N) is a potent inhibitor of FGFR1, FGFR2, and FGFR4, exhibiting IC50 values of 8 nM, 4 nM, and 3.8 nM respectively. It plays a crucial role in cancer research.Fórmula:C30H27Cl2N7O4Forma y color:SolidPeso molecular:620.49Masitinib mesylate
CAS:Masitinib mesylate (AB-1010 mesylate) is a selective and orally bioavailable c-Kit inhibitor (IC50 of 200 nM,540/800 nM,510 nM for human recombinant c-Kit;Fórmula:C29H34N6O4S2Pureza:100% - 97.67%Forma y color:SolidPeso molecular:594.75Ref: TM-T8544
5mg35,00€10mg51,00€25mg77,00€50mg95,00€100mg144,00€200mg225,00€500mg373,00€1mL*10mM (DMSO)49,00€SSR128129E free acid
CAS:SSR128129E free acid is an orally available and allosteric inhibitor of FGFR(IC50 of 1.9 μM for FGFR1).Fórmula:C18H16N2O4Pureza:98%Forma y color:SolidPeso molecular:324.33Bemarituzumab
CAS:Bemarituzumab: humanized IgG1 antibody inhibits FGFR2b, may be used in cancer research.Pureza:SDS-PAGE:95% SEC-HPLC:99.99%Forma y color:LiquidPeso molecular:144 kDaFGFR2-IN-2
CAS:FGFR2-IN-2 is a specific FGFR2 inhibitor that inhibits FGFR1, FGFR2, and FGFR3, and can be used in the study of cancer and cardiovascular disease.Fórmula:C23H22N4OPureza:98.09%Forma y color:SolidPeso molecular:370.45PHA-680632
CAS:PHA-680632 is potent inhibitor of Aurora A, Aurora B and Aurora C with IC50 of 27 nM, 135 nM and 120 nM, respectively.Fórmula:C28H35N7O2Pureza:98.20%Forma y color:SolidPeso molecular:501.62PD173074
CAS:PD173074 inhibits FGFR1 (IC50: 25 nM) and VEGFR2 (100-200 nM); ~1000x more selective for FGFR1 over PDGFR/c-Src.Fórmula:C28H41N7O3Pureza:98.15% - 98.21%Forma y color:Yellow SolidPeso molecular:523.67Ref: TM-T2642
5mg43,00€10mg57,00€25mg89,00€50mg140,00€100mg221,00€200mg393,00€500mg655,00€1mL*10mM (DMSO)59,00€Ferulic acid sodium
CAS:Ferulic acid sodium (Sodium ferulic) is an agent used in the treatment of cardiovascular and cerebrovascular diseases and to prevent thrombosis.Fórmula:C10H9NaO4Pureza:99.58%Forma y color:White Crystalline PowderPeso molecular:216.16FGFR4-IN-1
CAS:FGFR4-IN-1 is a potent FGFR4 inhibitor (IC50: 0.7 nM).Fórmula:C24H27N7O5Pureza:98.96%Forma y color:SolidPeso molecular:493.52FGFR1/DDR2 inhibitor 1
CAS:FGFR1/DDR2 inhibitor 1 is an inhibitor of discoindin domain receptor 2 (DDR2) and fibroblast growth factor receptor 1 (FGFR1), with IC50 values of 31.1 nM, 108Fórmula:C28H22F3N5OPureza:99.43%Forma y color:SolidPeso molecular:501.5Ref: TM-T11279
1mg92,00€5mg216,00€10mg354,00€25mg582,00€50mg802,00€100mg1.169,00€1mL*10mM (DMSO)240,00€CP-547632 hydrochloride
CAS:CP-547632 hydrochloride: oral VEGFR-2/FGF inhibitor (IC50: 11/9 nM), well-tolerated, antitumor.Fórmula:C20H25BrClF2N5O3SForma y color:SolidPeso molecular:568.86KW-2449
CAS:KW-2449 is a multiple-targeted inhibitor, mostly for Flt3, modestly effective to Bcr-Abl, FGFR1, and Aurora A; little inhibitory on PDGFRβ, IGF-1R, EGFR.Fórmula:C20H20N4OPureza:98.43% - 99.89%Forma y color:SolidPeso molecular:332.4FGFR2/3-IN-2
CAS:FGFR2/3-IN-2 (compound 10) is an orally active inhibitor targeting FGFR2 and FGFR3. It exhibits IC50 values of 3.7 nM for FGFR2 and 31.2 nM for FGFR3, with a pre-incubation time of 1 hour. FGFR2/3-IN-2 demonstrates selectivity over FGFR1/4 and other kinases, and does not cause diarrhea or increased serum phosphate in vivo. In the SNU-16 gastric cancer model, FGFR2/3-IN-2 can induce tumor stasis or regression.Fórmula:C29H23FN6O3Forma y color:SolidPeso molecular:522.53DGY-06-116
DGY-06-116 is an selective and irreversible covalent inhibitor of Src and FGFR1 with IC50 value of 3nM and 8340 nM, respectively.Fórmula:C32H33ClN8O2Pureza:97.65%Forma y color:SolidPeso molecular:597.11Ref: TM-T22306
2mg42,00€5mg64,00€10mg97,00€25mg183,00€50mg284,00€100mg425,00€200mg602,00€1mL*10mM (DMSO)70,00€SSR128129E
CAS:SSR128129E (SSR) is an allosteric and orally-active FGFR1 inhibitor (IC50: 1.9 μM), but not affecting other related RTKs.Fórmula:C18H15N2O4·NaPureza:98.79% - ≥95%Forma y color:SolidPeso molecular:346.31PD 173074
CAS:Fórmula:C28H41N7O3Pureza:>95.0%(HPLC)Forma y color:White to Yellow to Orange powder to crystalPeso molecular:523.68FIIN-1
CAS:FIIN-1 (FGFR irreversible inhibitor-1) is an irreversible and selective FGFR inhibitor with Kd of 2.8, 6.9, 5.4, 120, 32 and 120 nM for FGFR1, FGFR2, FGFR3,Fórmula:C32H39Cl2N7O4Pureza:97.30%Forma y color:SolidPeso molecular:656.6Ref: TM-T37426
1mg79,00€2mg103,00€5mg202,00€10mg329,00€25mg550,00€50mg783,00€100mg1.035,00€500mg2.118,00€PRN1371
CAS:PRN1371 is a specific and potent FGFR1-4 and CSF1R inhibitor (IC50s: 0.6/1.3/4.1/19.3/8.1 nM for FGFR1/2/3/4 and CSF1R).Fórmula:C26H30Cl2N6O4Pureza:98.65%Forma y color:SolidPeso molecular:561.46Ref: TM-TQ0015
1mg81,00€2mg105,00€5mg170,00€10mg305,00€25mg520,00€50mg748,00€100mg1.026,00€1mL*10mM (DMSO)212,00€Aprutumab
CAS:Aprutumab, a human FGFR2 monoclonal antibody, targets FGFR2-IIIB/C and is used in antibody-drug conjugates.Pureza:98.69% (SEC-HPLC) - 98.69% (SEC-HPLC)Forma y color:LiquidPeso molecular:150 kDa
